EnvisionIt Deep AI

Envisionit Deep AI, established in 2019, is a medical technology company focused on leveraging artificial intelligence to transform diagnostic imaging. The company was co-founded by Dr. Jaishree Naidoo, a pediatric radiologist with over two decades of experience; Terence Naidu, who handles business development; and Andrei Migatchev, the Chief Technology Officer with a background in IT. Dr. Naidoo's inspiration came in 2014 from an article on AI pattern recognition, which she realized could be applied to radiology to address the significant gap in diagnostic imaging services.

The company's core business revolves around developing and deploying AI-powered software solutions that assist healthcare professionals in analyzing medical images like X-rays, mammograms, and ultrasounds. Their primary product, RADIFY AI, is a platform designed to enhance the speed, accuracy, and affordability of medical imaging diagnosis. This technology can detect over 25 different pathologies, including critical diseases such as tuberculosis, pneumonia, and breast cancer. The platform is built to be deployable even in areas with limited infrastructure and can be integrated directly with imaging devices for point-of-care diagnostics. This capability is crucial in markets like Africa, where the ratio of radiologists to the population is extremely low. Envisionit also provides teleradiology services for patients needing radiology reports.

Envisionit Deep AI serves a range of clients, including academic and private hospitals, clinics, and occupational health screening services, with a specific focus on the mining sector in South Africa for early detection of lung diseases in workers. The company has also formed a significant partnership with pharmaceutical giant Bayer to explore further applications of its AI tools on Bayer's cloud-based platform for imaging technologies. Beyond diagnostic tools, the firm has developed a computer-assisted training model, CAT, to help medical practitioners acquire radiology skills. Another product, Ratify, is a real-time monitoring and validation platform for AI models used in clinical workflows. A key milestone was achieved in February 2023 when the company secured $1.65 million in funding from investors including New GX Ventures SA and the GIIG Africa Fund, intended to fuel its expansion beyond South Africa and pursue regulatory approvals from bodies like the FDA and the European Medical Agency.

Keywords: medical imaging AI, radiology AI, diagnostic imaging software, healthtech Africa, AI-powered diagnostics, teleradiology services, medical image analysis, RADIFY AI, Jaishree Naidoo, early disease detection, tuberculosis detection AI, pneumonia detection AI, breast cancer AI diagnosis, point-of-care diagnostics, healthcare technology, AI for radiologists, medical AI validation, computer-aided diagnosis, occupational health AI, AI in medicine, clinical workflow AI, South African healthtech